Common Equity: The sum of all common equity items.
Astellas Pharma Inc. (ALPMY) had Common Equity of $11.52B for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$13.45B |
|
$1.83B |
|
$2.57B |
|
$10.88B |
|
$11.05B |
|
$2.40B |
|
$-39.00M |
|
$2.37B |
|
$2.37B |
|
$1.83B |
|
$1.83B |
|
$1.83B |
|
$1.83B |
|
$2.40B |
|
$3.63B |
|
1.79B |
|
1.80B |
|
$1.02 |
|
$1.02 |
|
| Balance Sheet Financials | |
$8.94B |
|
$2.25B |
|
$13.49B |
|
$22.43B |
|
$7.66B |
|
$2.01B |
|
$3.26B |
|
$10.92B |
|
|
Common Equity |
$11.52B |
$2.47B |
|
$11.52B |
|
1.79B |
|
| Cash Flow Statement Financials | |
$3.52B |
|
$-420.00M |
|
$-2.55B |
|
$1.19B |
|
$1.77B |
|
$586.00M |
|
-- |
|
$-856.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.17 |
|
-- |
|
-- |
|
0.15 |
|
0.32 |
|
80.91% |
|
17.88% |
|
17.88% |
|
26.97% |
|
17.60% |
|
13.63% |
|
$3.16B |
|
-- |
|
-- |
|
-- |
|
0.60 |
|
1.23 |
|
2.81 |
|
129.98 |
|
15.92% |
|
74.21% |
|
8.17% |
|
13.55% |
|
$6.43 |
|
$1.76 |
|
$1.96 |
|